Amundi Portfolio holdings
Amundi, established in 2010 through the merger of Crédit Agricole and Société Générale’s asset management arms, is Europe’s largest asset management firm, headquartered in Paris, France, overseeing €2.2 trillion ($2.3 trillion USD) in assets as of late 2024. Serving institutional clients, financial advisors, and retail investors across 35 countries, Amundi offers a broad spectrum of investment solutions, including active and passive funds, ETFs, and sustainable investing options, with a strong focus on cost efficiency and ESG (environmental, social, governance) principles. The firm’s growth has been fueled by strategic acquisitions, such as Pioneer Investments in 2017 and Lyxor in 2021, enhancing its global reach and expertise in index tracking and alternatives. Majority-owned by Crédit Agricole, Amundi combines French financial heritage with a modern, client-centric approach, maintaining a dominant position in Europe while expanding in Asia and the Americas.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.03B |
| 2 |
McDonald's
MCD
|
+$609M |
| 3 |
UnitedHealth
UNH
|
+$598M |
| 4 |
Strategy Inc
MSTR
|
+$514M |
| 5 |
Qualcomm
QCOM
|
+$469M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.14B |
| 2 |
NVIDIA
NVDA
|
+$1.53B |
| 3 |
Eli Lilly
LLY
|
+$1.08B |
| 4 |
Mastercard
MA
|
+$996M |
| 5 |
Uber
UBER
|
+$932M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 34.27% |
| 2 | Consumer Discretionary | 12.49% |
| 3 | Financials | 11.57% |
| 4 | Healthcare | 9.6% |
| 5 | Communication Services | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Dover
DOV
$27.2B
| $118M | 0.04% |
624,864
-125,622
| -17% | -$21.9M |
|
377
Occidental Petroleum
OXY
$57B
| $117M | 0.04% |
2,672,048
-20,601
| -0.8% | -$861K |
|
378
Bunge Global
BG
$23.6B
| $117M | 0.04% |
1,477,573
+120,626
| +9% | +$9.49M |
|
379
Clorox
CLX
$11.6B
| $117M | 0.04% |
940,399
+10,108
| +1% | +$1.35M |
|
380
Extra Space Storage
EXR
$31.2B
| $117M | 0.04% |
771,509
+226,073
| +41% | +$32.9M |
|
381
CF Industries
CF
$19.2B
| $117M | 0.04% |
1,281,840
+472,592
| +58% | +$40.3M |
|
382
Corteva
CTVA
$59.7B
| $117M | 0.04% |
1,516,306
-234,571
| -13% | -$15.6M |
|
383
Cardinal Health
CAH
$53.4B
| $116M | 0.04% |
718,592
-1,183,078
| -62% | -$176M |
|
384
Centene
CNC
$31.3B
| $114M | 0.04% |
3,384,752
+199,016
| +6% | +$11.7M |
|
385
Honeywell
HON
$77.1B
| $113M | 0.04% |
501,160
-50,435
| -9% | -$10.2M |
|
386
Lennox International
LII
$18.8B
| $113M | 0.04% |
187,656
-1,915
| -1% | -$1.07M |
|
|
JNPR
387
DELISTED
Juniper Networks
JNPR
| $113M | 0.04% |
2,826,924
+1,167,529
| +70% | +$41.8M |
|
388
State Street
STT
$50.9B
| $112M | 0.04% |
1,044,807
-3,334,665
| -76% | -$308M |
|
389
West Pharmaceutical
WST
$23.1B
| $111M | 0.04% |
502,831
+228,696
| +83% | +$48.9M |
|
390
Bank of Montreal
BMO
$125B
| $110M | 0.04% |
983,846
+281,882
| +40% | +$28.4M |
|
391
Sabesp
SBS
$19.7B
| $110M | 0.04% |
30,312,365
-12,190
| -0% | -$47.2K |
|
392
Regency Centers
REG
$15B
| $108M | 0.04% |
1,530,276
+730,730
| +91% | +$52.2M |
|
393
Warner Bros
WBD
$64.6B
| $108M | 0.04% |
9,724,946
+414,078
| +4% | +$3.86M |
|
394
Vulcan Materials
VMC
$36.3B
| $108M | 0.04% |
406,570
+179,086
| +79% | +$46.1M |
|
395
ResMed
RMD
$28.3B
| $107M | 0.04% |
419,931
-211,218
| -33% | -$50.4M |
|
396
United Therapeutics
UTHR
$26.3B
| $107M | 0.04% |
362,826
+12,633
| +4% | +$3.78M |
|
397
PPG Industries
PPG
$25.9B
| $107M | 0.04% |
899,093
-199,931
| -18% | -$21.6M |
|
398
lululemon athletica
LULU
$13B
| $105M | 0.04% |
428,140
-197,642
| -32% | -$54.4M |
|
399
NRG Energy
NRG
$29.8B
| $105M | 0.04% |
676,735
-3,701,287
| -85% | -$488M |
|
400
PTC
PTC
$13.7B
| $105M | 0.04% |
639,926
+111,976
| +21% | +$18M |
|
Similar funds
Amundi's Q2 2025 Portfolio in Review
As of Q2 2025, Amundi held 2,245 positions worth $290B, up 5.5% from $275B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Amundi withdrew a net $25.8B in Q2 2025, closing 579 positions and reducing 831 holdings. Its most notable exit was Novo Nordisk, an estimated $332M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Amundi opened a new position in Victory Capital Holdings worth $213M.
- Amundi's largest Q2 2025 buy was Victory Capital Holdings: 3,293,471 shares worth $213M.
- Amundi added most to Tesla in Q2 2025, an estimated $1.03B increase.
- Amundi's biggest Q2 2025 reduction was Microsoft, cutting an estimated $3.14B.
- Amundi fully exited Novo Nordisk in Q2 2025, selling an estimated $332M.
- Amundi's ten largest holdings make up 31% of its $290B portfolio in Q2 2025.
- Amundi opened 66 new positions and closed 579 in Q2 2025.
- Amundi's portfolio value rose 5.5% quarter-over-quarter to $290B.
Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.